Ernexa Therapeutics Inc.

ERNA Nasdaq SEC CIK 748592
Follow Ernexa Therapeutics Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Net income −$2.9M −137.2% vs same quarter last year
EPS, diluted −$1.89
Operating cash flow −$3.2M −149.2% vs same quarter last year
Operating income −$3M −50% vs same quarter last year
Net income by quarter
−$5.8M
−$8.2M
−$3.1M
−$1.2M
−$1.5M
−$5.5M
−$4M
−$2.9M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$150M−$100M−$50M$0$50MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25-−$14.1M
FY24$582K−$44.5M
FY23$68K−$21.7M
FY22$0−$24.6M
FY21-−$122.5M
FY20$5.8M−$7.3M
FY19$19.8M−$2M
FY18$23.3M−$259K
FY17$21.3M−$1.1M
FY16$22.3M−$2.9M
FY15$24.5M−$7.2M
FY14$26M−$5M
FY13$23.7M−$1.1M
FY12$24.1M−$995K
FY11$23.9M−$3.4M
MarginsShare of revenue
  • Operating margin
  • Net margin
−40000%−30000%−20000%−10000%0%10000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearOperating marginNet margin
FY25--
FY24−2693.1%−7652.7%
FY23−31080.9%−31864.7%
FY22--
FY21--
FY20−125%−125.7%
FY19−8.9%−10.3%
FY180.9%−1.1%
FY17−6.6%−5.1%
FY16−10.2%−13.1%
FY15−28.1%−29.5%
FY14−18.2%−19.3%
FY13−4.7%−4.4%
FY12−4.4%−4.1%
FY11−13.7%−14.3%
Free cash flowOperating cash flow minus capital expenditure
−$30M−$20M−$10M$0$10MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$7.1M
FY24−$16.2M
FY23−$20.4M
FY22−$21.3M
FY21−$23.6M
FY20−$8.1M
FY19$2.6M
FY18$717K
FY17−$179K
FY16−$404K
FY15−$5.2M
FY14−$7.2M
FY13$632K
FY12$930K
FY11−$1M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Ernexa Therapeutics
  • Healthcare median
−40000%−30000%−20000%−10000%0%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearErnexa TherapeuticsHealthcare median
FY25-−30.6%
FY24−7652.7%−47%
FY23−31864.7%−58%
FY22-−80.4%
FY21-−71.9%
FY20−125.7%−62.2%
FY19−10.3%−46.3%
FY18−1.1%−49.6%
FY17−5.1%−45.9%
FY16−13.1%−36%
FY15−29.5%−38.4%
FY14−19.3%−35.5%
FY13−4.4%−37.1%
FY12−4.1%−29.1%
FY11−14.3%−27.9%